Pfizer sells US 200 million more COVID-19 vaccine shots, eyeing third doses
by Cassidy Morrison, Healthcare Reporter |
| July 23, 2021 10:07 AM
Pfizer and BioNTech announced they sold 200 million additional doses of their COVID-19 vaccine to the federal government, shots that could be tweaked to combat highly infectious mutated strains of the virus or used as third doses.
The company said Friday that the government "also has the option to acquire an updated version of the vaccine to address potential variants as well as new formulations of the vaccine."
The additional doses will be delivered to the government from October 2021 through April 2022, bringing the total supply of Pfizer shots purchased by the government to 500 million, plus 500 million more to be distributed globally.
more
https://www.washingtonexaminer.com/news/pfizer-sells-us-200-million-covid-vaccines-eyeing-third-doses
